Company Filing History:
Years Active: 2024-2025
Title: The Innovative Contributions of Zarife Sahenk
Introduction
Zarife Sahenk is a prominent inventor based in Columbus, OH (US). She has made significant contributions to the field of gene therapy, particularly in the treatment of muscular dystrophies. With a total of 2 patents, her work is paving the way for new therapeutic approaches.
Latest Patents
Sahenk's latest patents include groundbreaking innovations in the treatment of limb girdle muscular dystrophy 2A. One of her patents focuses on recombinant adeno-associated virus products and methods for treating this condition. The methods involve using recombinant adeno-associated viruses to deliver DNA that encodes a protein with calpain 3 activity. Another significant patent relates to NT-3 gene therapy, which utilizes recombinant adeno-associated virus delivery of a neurotrophin 3 (NT-3) polynucleotide. This therapy aims to improve muscle strength, stimulate muscle growth, and treat muscle-wasting disorders, including muscular dystrophy and Charcot-Marie-Tooth neuropathy.
Career Highlights
Zarife Sahenk is affiliated with the Research Institute at Nationwide Children's Hospital, where she conducts her research. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative therapies.
Conclusion
Zarife Sahenk's contributions to gene therapy and her innovative patents highlight her role as a leading inventor in the field. Her research continues to inspire advancements in the treatment of muscular dystrophies and related disorders.